Everhale Pharmaceuticals Private Limited
About Everhale Pharmaceuticals Private Limited
Data last updated:
Everhale Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 22 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2018PTC317364. Its GSTIN is 29AAFCE2713C1Z1 (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jose Shaji Erinjeri and Margret Madhu.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Flat C – 503 Tulsi Prerana New Panvel, Mumbai, Maharashtra, India – 410206.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat C – 503 Tulsi Prerana New Panvel, Mumbai, Maharashtra, India – 410206
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Everhale Pharmaceuticals Private Limited
The main business activity of Everhale Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Everhale Pharmaceuticals Private Limited FY 2022 filings available
Everhale Pharmaceuticals Private Limited reported revenue of ₹275 (up 175% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Everhale Pharmaceuticals Private Limited
Revenue rose 175% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Everhale Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Everhale Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Everhale Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Everhale Pharmaceuticals Private Limited
Everhale Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Whitecraft Pharmaceuticals Pvt Ltd | ₹380 (FY 2017) | •••• | •••• | -100.0% | •••• | Mumbai, Maharashtra, India |
| Sreint Pharmaceuticals Private Limited | ₹375 (FY 2022) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Mahur Pharmaceuticals Private Limited | ₹372 (FY 2025) | •••• | •••• | -77.0% | •••• | Mapusa, Goa, India |
| Ziveli Pharmaceuticals Private Limited | ₹325 (FY 2023) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Adiuvo Pharmaceuticals Private Limited | ₹285 (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Everhale Pharmaceuticals Private Limited this company | ₹275 (FY 2022) | •••• | •••• | 175.0% | •••• | Mumbai, Maharashtra, India |
| Kalpshri Pharmaceuticals Private Limited | ₹273 (FY 2025) | •••• | •••• | -100.0% | •••• | Noida, Uttar Pradesh, India |
| Benncare Pharmaceuticals Private Limited | ₹251 (FY 2019) | •••• | •••• | -95.0% | •••• | Cuttack, Odisha, India |
| Kumbha Pharmaceuticals Private Limited | ₹210 (FY 2022) | •••• | •••• | -100.0% | •••• | Kandivali (W) Mumbai, Maharashtra, India |
| Vivaswan Pharmaceuticals Private Limited | ₹172 (FY 2020) | •••• | •••• | -99.0% | •••• | Pune, Maharashtra, India |
| Jamkas Pharmaceuticals Private Limited | ₹155 (FY 2023) | •••• | •••• | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below Everhale Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Everhale Pharmaceuticals Private Limited
Everhale Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jose Shaji Erinjeri | Director | 22 Nov 2018 | 7 Years 10 Months | Current |
| Margret Madhu | Director | 22 Nov 2018 | 7 Years 10 Months | Current |
Ownership and Shareholding of Everhale Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Everhale Pharmaceuticals Private Limited
Everhale Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Everhale Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Everhale Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Everhale Pharmaceuticals Private Limited
Everhale Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Jose Shaji Erinjeri was appointed as Director on 22 Nov 2018.
Credit Ratings, Litigation & Regulatory Alerts for Everhale Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Everhale Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Everhale Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Everhale Pharmaceuticals Private Limited
Everhale Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCE2713C1Z1 | Karnataka | Active | 09 Apr 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Everhale Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Everhale Pharmaceuticals Private Limited
Everhale Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 22 November 2018 (8+ years old) and is registered under CIN U51909MH2018PTC317364.
Everhale Pharmaceuticals has 2 current directors:
- Jose Shaji Erinjeri - Director
- Margret Madhu - Director
The GSTIN of Everhale Pharmaceuticals is 29AAFCE2713C1Z1, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Everhale Pharmaceuticals is U51909MH2018PTC317364. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Everhale Pharmaceuticals was incorporated on 22 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Everhale Pharmaceuticals by revenue are Whitecraft Pharmaceuticals Pvt Ltd, Sreint Pharmaceuticals Private Limited, Mahur Pharmaceuticals Private Limited, Ziveli Pharmaceuticals Private Limited, Adiuvo Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Jose Shaji Erinjeri was appointed as Director on 22 Nov 2018. Margret Madhu was appointed as Director on 22 Nov 2018.
The registered office of Everhale Pharmaceuticals is at Flat C – 503 Tulsi Prerana New Panvel, Mumbai, Maharashtra, India – 410206.
Everhale Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Everhale Pharmaceuticals operates in the trading industry, in the specialty segment.
No. Everhale Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.